Margaret Garin Email
VP Clinical Development . Trevi Therapeutics
How to contact Margaret Garin
Join and see Margaret's contact info for free!Current Roles
Employees:
35Revenue:
$5.4MAbout
Trevi is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions. Trevi is currently developing nalbuphine ER for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in patients with Parkinson's disease. The conditions share a common pathophysiology that is mediated through opioid receptors in the central and peripheral nervous systems. Founded in 2011, Trevi is headquartered in New Haven, CT.Trevi Therapeutics Address
195 Church StreetNew Haven, CT
United States